News & Updates

Show Multimedia Only
Hypertrophic cardiomyopathy on the rise Hypertrophic cardiomyopathy on the rise

Hypertrophic cardiomyopathy on the rise

02 Nov 2022

In Japan, the prevalence of hypertrophic cardiomyopathy (HCM), regardless of subtype, increased between 2016 and 2020, a recent study has found.

02 Nov 2022
4 anti-obesity meds: AGA top picks

4 anti-obesity meds: AGA top picks

01 Nov 2022 byElvira Manzano

Obese adults with weight-related complications who do not respond adequately to lifestyle interventions should be offered one of four anti-obesity medications, according to the new clinical practice guideline on pharmacological interventions released by the American Gastroenterological Association (AGA).

01 Nov 2022
Nelonemdaz safe but fails to improve outcomes in stroke

Nelonemdaz safe but fails to improve outcomes in stroke

01 Nov 2022

Treatment with nelonemdaz, a multitarget neuroprotectant that selectively blocks N-methyl-D-aspartate receptors and scavenges free radicals, does not appear to significantly improve stroke outcomes as compared with placebo, although nelonemdaz-treated patients show a greater tendency toward achieving modified Rankin Scale scores of 0–2 at 12 weeks, according to the results of a phase II study.

01 Nov 2022